Notices. Notice
223 words·~1 min read·
/register/2013/05/14/2013-11364A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4154-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0902] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Prescription Drug Product Labeling; Medication Guide Requirements AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing that a collection of information entitled “Prescription Drug Product Labeling; Medication Guide Requirements” has been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-7726, *ila.mizrachi@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: On April 30, 2012, the Agency submitted a proposed collection of information entitled “Prescription Drug Product Labeling; Medication Guide Requirements” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0393. The approval expires on January 31, 2016. A copy of the supporting statement for this information collection is available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.* Dated: May 8, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013-11364 Filed 5-13-13; 8:45 am]
Connectionstraces to 1
Traces to 1 document